Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Feedback
    • Reprint Information
    • Subscriptions
  • ASN Kidney News
  • Other
    • ASN Publications
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Feedback
    • Reprint Information
    • Subscriptions
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum
Original ArticlesRenal Transplantation
You have accessRestricted Access

Emotional and Financial Experiences of Kidney Donors over the Past 50 Years: The RELIVE Study

Cheryl L. Jacobs, Cynthia R. Gross, Emily E. Messersmith, Barry A. Hong, Brenda W. Gillespie, Peg Hill-Callahan, Sandra J. Taler, Sheila G. Jowsey, Tim J. Beebe, Arthur J. Matas, Jonah Odim and Hassan N. Ibrahim
CJASN December 2015, 10 (12) 2221-2231; DOI: https://doi.org/10.2215/CJN.07120714
Cheryl L. Jacobs
Due to the number of contributing authors, the affiliations are provided in the .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cynthia R. Gross
Due to the number of contributing authors, the affiliations are provided in the .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily E. Messersmith
Due to the number of contributing authors, the affiliations are provided in the .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barry A. Hong
Due to the number of contributing authors, the affiliations are provided in the .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brenda W. Gillespie
Due to the number of contributing authors, the affiliations are provided in the .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peg Hill-Callahan
Due to the number of contributing authors, the affiliations are provided in the .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra J. Taler
Due to the number of contributing authors, the affiliations are provided in the .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sheila G. Jowsey
Due to the number of contributing authors, the affiliations are provided in the .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim J. Beebe
Due to the number of contributing authors, the affiliations are provided in the .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arthur J. Matas
Due to the number of contributing authors, the affiliations are provided in the .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonah Odim
Due to the number of contributing authors, the affiliations are provided in the .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hassan N. Ibrahim
Due to the number of contributing authors, the affiliations are provided in the .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Abstract

Background and objectives Most kidney donors view their experience positively, but some may experience psychosocial and financial burdens. We hypothesized that certain donor characteristics, poor outcome of the recipient, negative perceptions of care, and lack of support may be associated with poor psychosocial outcomes for donors.

Design, setting, participants, & measurements The Renal and Lung Living Donors Evaluation Study (RELIVE) examined long-term medical and psychosocial outcomes for kidney donors (at three U.S. transplant centers) who donated between 1963 and 2005. Standardized questionnaires evaluated donor perspectives, recovery time, social support, motivation, financial impact, insurability after donation, and current psychological status. Questionnaires were mailed to 6909 donors.

Results Questionnaires were returned by 2455 donors, who had donated 17±10 years earlier (range, 5–48 years), a response rate of 36%. Most (95%) rated their overall donation experience as good to excellent. Rating the overall donor experience more negatively was associated with donor complications, psychological difficulties, recipient graft failure, and longer time since donation. Nine percent (n=231) reported one or more of the following poor psychosocial outcomes: fair or poor overall donor experience, financial burden, regret or discomfort with decision to donate, or psychological difficulties since donation. Recipient graft failure was the only predictor for reporting one or more of these poor psychosocial outcomes (odds ratio, 1.77; 95% confidence interval, 1.33 to 2.34). Donors with lower educational attainment experienced greater financial burden. One of five employed donors took unpaid leave; 2% reported health and life insurability concerns.

Conclusions Although the majority of donors viewed their overall donation experience positively, almost 1 in 10 donors reported at least one negative consequence related to donation. Recipient graft failure was associated with poor psychosocial outcome, defined as one or more of these negative consequences. Some donors were financially disadvantaged, and some experienced insurance difficulties. Interventions to avoid negative psychosocial and financial consequences are warranted.

  • kidney donation
  • quality of life
  • renal transplantation
  • cost of illness
  • emotions
  • living donors
  • motivation
  • social support
  • tissue donors
  • vulnerable populations

Introduction

Most kidney donors experience psychosocial benefits, including improved self-esteem and donor-recipient relationships (1–5); likewise, most report no regrets (6,7) and reaffirm their decision to donate (3,8–13). However, these experiences are not universal. Predonation ambivalence, compromised mental health, strained relationship with the recipient, lack of financial resources, and pressure regarding donation are associated with poor psychological outcomes (14–22). Postdonation factors, such as lack of support, complications, or lack of health insurance, may prevent donors from seeking recommended medical or psychological follow-up, further interfering with recovery. Known psychosocial risks after surgery must be revealed during the education process in an attempt to avoid problems afterward and assure informed consent. Consequently, it is critical that transplant centers collect this information after donation and attend to those needing intervention.

Most data regarding this topic come from single-center studies with small numbers and limited follow-up. An exception is the Renal and Lung Living Donors Evaluation Study (RELIVE), which examined the medical and psychosocial status of 2455 kidney donors at three major U.S. transplant centers, who donated between 1963 and 2005, from questionnaires and examinations completed 5–48 years after donation; quality of life results for this cohort have been reported (23). We hypothesized that a poor psychosocial outcome (e.g., rating the overall donation experience negatively or recalling adverse psychological or financial effects, discomfort, or regret about decision to donate) would be associated with certain donor characteristics, negative recipient outcome, and negative perceptions of support.

Materials and Methods

Questionnaire and Ethical Considerations

Eligible participants donated between June 1963 and June 2005 at the University of Minnesota, Minneapolis, Minnesota; Mayo Clinic, Rochester, Minnesota; and the University of Alabama, Birmingham, Alabama (Supplemental Figure 1). Demographic characteristics were collected by chart review. A packet was mailed to 6909 donors believed to be living (of an original cohort of 8951 donors); the packet included a cover letter, consent form, and 11-page questionnaire. Nonrespondents were mailed a second packet at 4 weeks; they were called if they hadn’t returned the packet after another 2 weeks. Efforts to obtain correct contact information for nonresponding donors were made through the Social Security system. Data were collected between 2010 and 2012.

The questionnaire evaluated psychosocial, financial, and donor-specific outcomes after nephrectomy. Questions emphasized donor experience, recovery, current psychological status, motivation, interpersonal relationship with recipient, support available, financial effects, and long-term insurability. Questions were adapted from previous donor surveys, including studies by the authors (8,23), and the extensive donor research conducted by Simmons et al. (14). For this analysis, we grouped the following individual responses as a composite endpoint to define “poor psychosocial outcome”: (1) fair or poor overall donation experience; (2) great or extreme financial burden due to donation; (3) probably or definitely would not donate again in response to a hypothetical question; (4) emotional, psychological, or substance use difficulty because of donation; or (5) somewhat or very uncomfortable with decision to donate. We assessed clarity, relevance, and validity of our questionnaire through cognitive interviewing in a RELIVE pilot study with a diverse sample of donors. (See Supplemental Material; study details are available elsewhere [24–26].)

The institutional review board approved the study sites and the data coordinating center; participants provided written informed consent.

Statistical Analyses

Donor and recipient demographic data are presented as frequencies and percentages for categorical outcomes or as means±SDs for continuous variables. Wilcoxon rank-sum tests compared groups, and multivariable models examined relationships between demographic characteristics and donor perceptions. Logistic, multinomial, and linear regression analyses were performed to identify variables associated with donor outcomes. Independent variables were donation age, time (years from donation), sex, race, educational attainment at donation, recipient death or graft failure, relationship to recipient, surgical procedure, and donor-reported complications. To create models, we used a best subsets approach; the final models were selected on the basis of model fit, explained variance, and statistical significance of predictors.

Multiple imputation methods were used for regression covariates with missing data (27). SEMs of multiple imputed data were increased to account for additional uncertainty, thus minimizing the chance of making incorrect inferences. Statistical data analyses were performed using SAS software, version 9.2 (28). Results were considered statistically significant at P<0.01.

Results

Donor Characteristics

Among 8951 kidney donors, 6909 were thought to be alive and to have donated on or before June 30, 2005. Of the 6909 eligible donors, 14% (938) had no current address and 36% (2501) did not respond to the invitation to participate (totaling 3439). Of the remaining 3470 eligible donors, 2455 (36% of the 6,909) returned the questionnaire (enrollment details in Supplemental Figure 1). All nonparticipants (n=3516) had lower educational attainment at donation (odds ratio [OR], 0.75; 95% confidence interval [CI], 0.70 to 0.80); were younger at donation (OR, 0.98; 95% CI, 0.98 to 0.99); and were more likely to be black (OR, 2.43; 95% CI, 1.95 to 3.03), male (OR, 1.28; 95% CI, 1.15 to 1.43), and related to their recipient (OR, 1.72; 95% CI, 1.43 to 2.07) compared with participants (n=2455).

Most respondents were white (93%) and women (61%) and were related to their recipient (78%) (Table 1). The mean time from donation was 17±10 years (range, 5–48 years); 30% donated before 1990, 32% from 1990 to 1999, and 38% from 2000 to 2005. Most (79%) were <50 years of age at donation, and the average age was 58±11 years at survey completion. Respondents were highly educated; 37% had some post–high school education, 21% had a 4-year college degree, and 18% had a postgraduate degree. Most (75%) lived with a spouse or significant other.

View this table:
  • View inline
  • View popup
Table 1.

Donor and recipient characteristics

Donor Health Status

While most donors (80%) had no medical complications, 8% reported a longer hospitalization than expected or readmission, and 14% reported outpatient medical problems (Table 2). Eighty-seven (4%) reported active treatment for donor-related concerns. Ninety-nine donors (4%) attributed emotional, psychological, or substance use difficulties to donation; of these, nearly a third (29%) had a predonation history of psychiatric conditions or substance abuse, and 2% continued receiving psychiatric care for issues attributed to donation.

View this table:
  • View inline
  • View popup
Table 2.

Summary of positive, negative, and neutral perceptions related to donation (n=2455)

Recipient Status

Almost all (99%) respondents knew their recipient’s status and kidney function (Tables 1 and 2): Forty-seven percent reported their recipient was alive with kidney function, 12% reported the kidney was not functioning but recipient was alive, and 39% reported their recipient had died.

Primary Reason for Donation

Most (91%) were motivated by love for their recipient, 72% said donation was a logical response, 42% were influenced by faith, and 37% believed it was their moral obligation (Supplemental Figure 2).

However, 10% donated because family or friends expected them to, 5% felt pressure to donate, and 12% felt pressure not to donate. Siblings were most likely to feel pressure to donate (z score, 6.43; P<0.001). Unrelated donors were more likely to feel pressure from others not to donate (z score, 9.14; P<0.001).

In a multinomial regression, those asked to donate by their recipient (17%) were more likely related to the recipient (OR, 2.18; 95% CI, 1.42 to 3.35), male (OR, 1.49; 95% CI, 1.20 to 1.85), and longer out from donation (OR, 1.20; 95% CI, 1.07 to 1.34) compared with those autonomously initiating donation (79%) (Table 3).

View this table:
  • View inline
  • View popup
Table 3.

Results of multivariable models predicting donation related outcomes

Recovery Time

The majority (92%) reported returning to functional activities (i.e., daily routine obligations) within 3 months, but only 73% reported nephrectomy recovery within 3 months. Five percent needed >6 months to recover while 0.4% said they never fully recovered (Table 2). Shorter recovery time was reported by white donors (β=−0.13; 95% CI, −0.22 to −0.04) and those who underwent laparoscopic nephrectomy (β=−0.10; 95% CI, −0.15 to −0.05). Results are the equivalent of a recovery time of 1.31 points (on a 4-point scale) for a white donor versus 1.44 points for a nonwhite donor and a recovery time of 1.25 points (on a 4-point scale) for a donor with a laparoscopic procedure versus 1.35 points for a donor with an open procedure. Additional interpretations of regression results are presented in the Supplemental Material. Daily activities were resumed sooner by white donors (β=−0.16; 95% CI, −0.21 to −0.11) and those with higher educational attainment (β=−0.02; 95% CI, −0.03 to 0.00) (Table 3). Recovery time shorter than expected was experienced by men (β=−0.15; 95% CI, −0.24 to −0.05) and those who underwent laparoscopic nephrectomy (β=−0.24; 95% CI, −0.34 to −0.14).

Social Support

Six percent of donors felt they lacked support from family and friends during donation. Related donors were more likely than unrelated donors to feel family or friends’ support (β=0.17; 95% CI, 0.07 to 0.27). Donors experiencing emotional difficulty related to donation were less likely to feel supported by family or friends (β=−0.39; 95% CI, −0.54 to −0.23). Of employed donors, 82% felt their employer was supportive.

Sixty-two percent of donors felt that health care providers were supportive after surgery, 20% did not, and 17% were unsure. Older donors (β=0.07; 95% CI, 0.03 to 0.11) and men (β=0.16; 95% CI, 0.07 to 0.26) felt more support from health care providers. Nine percent agreed that “nobody paid much attention” to them after donation. Donors reporting postoperative medical complications (β=−0.31; 95% CI, −0.43 to −0.19) or emotional difficulties (β=−0.68; 95% CI, −0.90 to −0.45) were less likely to feel support from health care providers.

Current Donor-Recipient Relationship

Most donors (75%) felt that donation had positively influenced their relationship with their recipient (Table 2). Of donors whose recipient was still alive, most (79%) felt closer to them, 28% believed their recipients felt indebted to them, and 7% believed their recipient did not show enough gratitude.

Predictors of outcomes regarding the donor-recipient relationship are shown in Table 3. Respondents who were older at donation felt closer to their recipient after nephrectomy (β=0.08; 95% CI, 0.03 to 0.13) and were less likely to feel that their recipient did not show enough gratitude (β=−0.09; 95% CI, −0.13 to −0.04).

Feeling closer to the recipient was less common among donors experiencing emotional difficulty after donation (β=−0.58; 95% CI, -−0.87 to −0.28). Donors were more inclined to feel that their recipient did not adequately show gratitude if they experienced a medical complication (β=0.32; 95% CI, 0.20 to 0.44) or emotional difficulty (β=0.63; 95% CI, 0.36 to 0.90) after donation. Donors who were offspring (β=0.61; 95% CI, 0.35 to 0.88), parents (β=0.56; 95% CI, 0.33 to 0.79), siblings (β=0.35; 95% CI, 0.13 to 0.57), spouses (β=0.55; 95% CI, 0.29 to 0.81), or friends (β=0.46; 95% CI, 0.20 to 0.73) claimed that their relationship with their recipient grew stronger compared with unrelated donors (Table 3).

Parental (β=−0.69; 95% CI, −0.97 to −0.41) and spousal (β=−0.42; 95% CI, −0.74 to −0.11) donors were least likely to think their recipient felt indebted; children who donated to parents felt their recipients showed gratitude (β=−0.33; 95% CI, −0.58 to −0.09). Donors whose recipients had a graft that no longer functioned reported that the recipients felt less indebted than recipients with graft function or whose graft status was unknown (β=−0.32; 95% CI, −0.47 to −0.16).

Perceived Overall Experience

Most donors (95%) rated their overall donor experience as good to excellent (Supplemental Figure 3). Table 3 demonstrates that donors with medical complications (β=−0.49; 95% CI, −0.57 to −0.40) or emotional difficulty (β=−0.93; 95% CI, −1.09 to −0.76) and those who donated longer ago (β=−0.05; 95% CI, −0.09 to −0.01) rated their experience more negatively. Donors whose graft still functioned or who did not know the graft status were the most positive about their overall donation experience (β=−0.11; 95% CI, −0.18 to −0.04).

Most (96%) were comfortable with their decision to donate; 94% would donate again, but 1.2% would probably, or definitely, not donate again. The decision to donate was more often affirmed by white donors (β=0.14; 95% CI, 0.05 to 0.22) and by related donors (β=0.10; 95% CI, 0.03 to 0.17) (Table 3). Those less likely to affirm their donation decision were donors with a medical complication (β=−0.09; 95% CI, −0.15 to −0.03), an emotional difficulty (β=−0.44; 95% CI, −0.55 to −0.33), or donated longer ago (β=−0.04; 95% CI, −0.06 to −0.01) (Table 3).

Donors felt donation had positive effects on their recipient’s general health (92%), their own meaning of life (65%), and self-perception (50%) (Supplemental Figure 4).

Financial Experience

Some donors (5%) reported problems paying routine monthly household bills (Table 4). Donation caused financial burden to 20% of donors. Greater financial problems were more likely in those with medical complications (β=0.18; 95% CI, 0.11 to 0.25) or emotional difficulty (β=0.65; 95% CI, 0.52 to 0.78). Problems covering monthly bills were more likely in recent donors (OR, 0.75; 95% CI, 0.60 to 0.93). Older donors and those with higher education were less likely to have difficulty paying household bills (OR, 0.62 [95% CI, 0.51 to 0.75] and 0.58 [95% CI, 0.46–0.73], respectively) and experienced less financial burden (β=−0.05 [95% CI, −0.07 to −0.02] and −0.06 [95% CI, −0.08 to −0.03], respectively).

View this table:
  • View inline
  • View popup
Table 4.

Donors reporting financial issues related to donation

Nearly 20% of donors (18.8%) took unpaid work leave. Some reported negative impacts on insurability: 1.8% were denied health insurance and 2.1% were denied life insurance (Table 4). Problems paying donor-related medical bills were reported by 1.7%.

Predictors of Poor Psychosocial Outcome

Separately from rating just the overall donor experience (above), we defined a poor psychosocial outcome as when one or more of the following was reported: (1) fair or poor overall donation experience (n=114); (2) great or extreme financial burden due to donation (n=45); (3) probably or definitely would not donate again (n=29); (4) emotional, psychological, or substance use difficulty because of donation (n=99); or (5) somewhat or very uncomfortable with decision to donate (n=27). In total, 231 donors (9%) met this definition. Of these, 172 (74%) reported a single area, 42 (18%) reported two, 10 (4%) reported three, seven (3%) reported four, and no donor experienced all five. Nearly half (49%) of the donors (114 of 231) with a poor psychosocial outcome by this composite variable rated their overall donation experience as fair or poor. The only factor associated with the composite poor psychosocial outcome variable was recipient graft failure (OR, 1.77; 95% CI, 1.33 to 2.34) (Table 3).

Discussion

Our results reaffirm that most living kidney donors had a positive donor experience, were satisfied with their decision to donate, didn’t feel pressured, and were not negatively affected over time. Nevertheless, some reported adverse psychosocial and financial consequences related to donation.

A few donors felt pressure to donate; they were more likely to be siblings, consistent with prior reports (9,23,29,30). Unrelated donors felt pressure not to donate. Resistance to donation by others may occur when individuals don’t know their recipient or are without direct attachment or benefit (31,32). Assessing levels of pressure in these two groups might be heightened.

Fewer than 10% of donors experienced one or more of the negative psychosocial or financial consequences that made up our definition of poor psychosocial outcome, and recipient graft failure, the only predictor of this composite outcome, is unknown before donation.

In addition, unrelated donors and those with emotional difficulty after donation were more likely to feel unsupported. The finding regarding unrelated donors is crucial because living donor transplants among individuals with no prior relationship to their recipient continue to increase (e.g., public solicitations, nondirected donations).

The Organ Procurement and Transplantation Network policy requires that centers complete follow-up surveys on each donor (33). Data related to medical/psychological complications, lifestyle changes, and financial impact can be collected simultaneously. Enriching national donor data after donation could allow for tailored donor follow-up.

Lost wages and unpaid time off (affecting nearly 20% of this sample) should be addressed. Donor reimbursement programs might consider the direction of the National Bone Marrow Program, which covers donor-associated travel expenses for donors and a companion, regardless of economic status (34). Klarenbach et al. quantified donor expenses and recommended cost neutrality options (35), while LaPointe et al. suggested ways to financially support donors (36).

Of concern, 38% of our cohort did not feel supported by hospital staff. Donors with postoperative complications felt ignored by both hospital staff and family, similar to other studies reporting that donors “feel forgotten” after donation (3,8,11,16,18,37,38). Our study reinforces on a grander scale the need for improved attention afterward.

One in 20 donors experienced a moderate to extreme financial burden attributable to donation. After donation, 19% took unpaid leave—in effect, a fiscal donation and additional sacrifice on their part. Reimer et al. reported that 25% of donors needed to resume work before feeling fully rehabilitated, an observation similar to ours (11). Those with medical or emotional complications, and those with lower education attainment, were more likely to report problems paying household bills because of donation.

Apart from direct and indirect costs, donors find future insurability a stressor (40,41). Yang et al. reported that 2%–11% of donors had problems obtaining insurance after donation (17). In our study, some respondents were denied health or life insurance (1.8% and 2.1%, respectively). Given the demographic characteristics of respondents versus nonrespondents, we believe those are an underestimate: More nonrespondents were from groups (younger, male, and ethnic minorities) that are less likely to have health insurance at donation (42). Additionally, lack of health insurance may impede some from seeking medical or psychological follow-up.

Recipient graft failure was a statistically significant predictor of the composite poor psychosocial outcome, consistent with reports from smaller studies (8). Tong and colleagues' review verified that “the donor’s well-being ‘depended’ on the well-being of the recipient,” and feelings of regret, sense of loss, or psychiatric complications were reported when the recipient died or had a poor outcome (43).

Our study provides information on the largest number of donors to date and extends over five decades. However, there are limitations. First, our data are limited to information from three large transplant centers. Second, response rates were less than ideal; differences between respondents and nonrespondents exist. Donors with similar demographic characteristics might not respond at different points in their lives for various reasons; information from previous time points was unavailable for donors who had died. Therefore, response and survival bias are obvious limitations. Third, recall bias is an inherent limitation of any study with this design, and donors might not be accurately recalling items directly related to donation but rather might be thinking of current life circumstances. Fourth, we chose not to test for center effects, in part because we were interested in testing for racial differences and race was somewhat confounded with center. In addition, we had no hypotheses regarding center-level differences on donor outcomes and did not collect center-level data that could be used to explain differences. Finally, only 6% of participants were nonwhite. Participants may not represent regional or national living donor demographics over the same time span because response rates were lower in the nonwhite subgroup.

Our data support the following recommendations to improve psychosocial outcomes for donors:

  • The hospital should enhance their support of donors, especially those with postoperative complications.

  • Donor programs should give additional consideration to donors whose recipient’s graft has failed, and to those who are unrelated or experiencing emotional difficulty.

  • Tailored donor follow-up to improve the donor’s psychosocial well-being should be studied. The Centers for Medicare & Medicaid Services could incorporate psychosocial/financial status questions into existing follow-up interval surveys (beyond medical follow-up) to determine (and prioritize) areas needing attention.

  • A donor financial plan addressing income concerns should be confirmed before donation to minimize economic distress postdonation. Further studies should be conducted that deal with promoting cost neutrality.

In conclusion, the RELIVE cohort of donors spanning 50 years indicates that the majority had a positive donation experience. Rating the overall donation experience more negatively was associated with recipient graft failure, donor medical complications or emotional difficulty, and having donated longer ago. Recipient graft failure was the only statistically significant predictor of poor psychosocial outcome, as defined in this study. In addition, some donors were financially disadvantaged. Enhanced postdonation monitoring and attention to donors at greater psychosocial risk may improve long-term donor outcomes.

Disclosures

None.

Acknowledgments

This research was performed as a project of the Renal and Lung Living Donors Evaluation Study (RELIVE) project, a collaborative clinical research study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), Health Resources and Services Administration (HRSA), and the National Heart Lung and Blood Institute (NHLBI.)

Jennifer McCready-Maynes, an employee of Arbor Research Collaborative for Health, provided editorial assistance on the paper.

Footnotes

  • Published online ahead of print. Publication date available at www.cjasn.org.

  • This article contains supplemental material online at http://cjasn.asnjournals.org/lookup/suppl/doi:10.2215/CJN.07120714/-/DCSupplemental.

  • Received July 17, 2015.
  • Accepted September 2, 2015.
  • Copyright © 2015 by the American Society of Nephrology

References

  1. ↵
    1. Clemens KK,
    2. Thiessen-Philbrook H,
    3. Parikh CR,
    4. Yang RC,
    5. Karley ML,
    6. Boudville N,
    7. Ramesh Prasad GV,
    8. Garg AX,
    9. Donor Nephrectomy Outcomes Research (DONOR) Network
    : Psychosocial health of living kidney donors: A systematic review. Am J Transplant 6: 2965–2977, 2006
    OpenUrlCrossRefPubMed
    1. Tan HP,
    2. Marcos A,
    3. Shapiro R
    1. Dew MA,
    2. Switzer GE,
    3. DiMartini AF,
    4. Mayaskovsky L,
    5. Matoka MC
    : Psychosocial aspects of living organ donation. In: Living Donor Organ Transplantation, edited by Tan HP, Marcos A, Shapiro R, New York, Taylor & Francis, 2007, pp 7–26
  2. ↵
    1. Schover LR,
    2. Streem SB,
    3. Boparai N,
    4. Duriak K,
    5. Novick AC
    : The psychosocial impact of donating a kidney: Long-term follow-up from a urology based center. J Urol 157: 1596–1601, 1997pmid:9112484
    OpenUrlCrossRefPubMed
    1. Fellner CH,
    2. Marshall JR
    : Twelve kidney donors. JAMA 206: 2703–2707, 1968pmid:4880430
    OpenUrlCrossRefPubMed
  3. ↵
    1. Fehrman-Ekholm I,
    2. Brink B,
    3. Ericsson C,
    4. Elinder CG,
    5. Dunér F,
    6. Lundgren G
    : Kidney donors don’t regret: Follow-up of 370 donors in Stockholm since 1964. Transplantation 69: 2067–2071, 2000pmid:10852598
    OpenUrlCrossRefPubMed
  4. ↵
    1. Sharp J,
    2. McRae A,
    3. McNeill Y
    : Decision making and psychosocial outcomes among living kidney donors: A pilot study. Prog Transplant 20: 53–57, 2010pmid:20397347
    OpenUrlCrossRefPubMed
  5. ↵
    1. Clemens K,
    2. Boudville N,
    3. Dew MA,
    4. Geddes C,
    5. Gill JS,
    6. Jassal V,
    7. Klarenbach S,
    8. Knoll G,
    9. Muirhead N,
    10. Prasad GV,
    11. Storsley L,
    12. Treleaven D,
    13. Garg AX,
    14. Donor Nephrectomy Outcomes Research (DONOR) Network
    : The long-term quality of life of living kidney donors: A multicenter cohort study. Am J Transplant 11: 463–469, 2011pmid:21342446
    OpenUrlCrossRefPubMed
  6. ↵
    1. Johnson EM,
    2. Anderson JK,
    3. Jacobs C,
    4. Suh G,
    5. Humar A,
    6. Suhr BD,
    7. Kerr SR,
    8. Matas AJ
    : Long-term follow-up of living kidney donors: Quality of life after donation. Transplantation 67: 717–721, 1999pmid:10096528
    OpenUrlCrossRefPubMed
  7. ↵
    1. Smith MD,
    2. Kappell DF,
    3. Province MA,
    4. Hong BA,
    5. Robson AM,
    6. Dutton S,
    7. Guzman T,
    8. Hoff J,
    9. Shelton L,
    10. Cameron E,
    11. Emerson W,
    12. Glass NR,
    13. Hopkins J,
    14. Peterson C
    : Living-related kidney donors: A multicenter study of donor education, socioeconomic adjustment, and rehabilitation. Am J Kidney Dis 8: 223–233, 1986pmid:3532770
    OpenUrlCrossRefPubMed
    1. Nolan MT,
    2. Walton-Moss B,
    3. Taylor L,
    4. Dane K
    : Living kidney donor decision making: State of the science and directions for future research. Prog Transplant 14: 201–209, 2004pmid:15495779
    OpenUrlCrossRefPubMed
  8. ↵
    1. Reimer J,
    2. Rensing A,
    3. Haasen C,
    4. Philipp T,
    5. Pietruck F,
    6. Franke GH
    : The impact of living-related kidney transplantation on the donor’s life. Transplantation 81: 1268–1273, 2006pmid:16699453
    OpenUrlCrossRefPubMed
    1. Frade IC,
    2. Fonseca I,
    3. Dias L,
    4. Henriques AC,
    5. Martins LS,
    6. Santos J,
    7. Sarmento M,
    8. Lopes A
    : Impact assessment in living kidney donation: Psychosocial aspects in the donor. Transplant Proc 40: 677–681, 2008pmid:18454984
    OpenUrlCrossRefPubMed
  9. ↵
    1. Jordan J,
    2. Sann U,
    3. Janton A,
    4. Gossmann J,
    5. Kramer W,
    6. Kachel HG,
    7. Wilhelm A,
    8. Scheuermann E
    : Living kidney donors’ long-term psychological status and health behavior after nephrectomy—A retrospective study. J Nephrol 17: 728–735, 2004pmid:15593042
    OpenUrlPubMed
  10. ↵
    1. Simmons RG,
    2. Klein SD,
    3. Simmons RC
    : Gift of Life: The Social and Psychological Impact of Organ Transplantation. New Brunswick, NJ, Transaction Books, 1987
    1. Giessing M,
    2. Reuter S,
    3. Schönberger B,
    4. Deger S,
    5. Tuerk I,
    6. Hirte I,
    7. Budde K,
    8. Fritsche L,
    9. Morgera S,
    10. Neumayer HH,
    11. Loening SA
    : Quality of life of living kidney donors in Germany: A survey with the Validated Short Form-36 and Giessen Subjective Complaints List-24 questionnaires. Transplantation 78: 864–872, 2004pmid:15385806
    OpenUrlCrossRefPubMed
  11. ↵
    1. Fehrman-Ekholm I,
    2. Tydén G
    : Donors need support too. Transplantation 78: 787, 2004pmid:15385795
    OpenUrlCrossRefPubMed
  12. ↵
    1. Yang RC,
    2. Thiessen-Philbrook H,
    3. Klarenbach S,
    4. Vlaicu S,
    5. Garg AX,
    6. Donor Nephrectomy Outcomes Research (DONOR) Network
    : Insurability of living organ donors: A systematic review. Am J Transplant 7: 1542–1551, 2007pmid:17430400
    OpenUrlCrossRefPubMed
  13. ↵
    1. Erim Y,
    2. Senf W,
    3. Heitfeld M
    : Psychosocial impact of living donation. Transplant Proc 35: 911–912, 2003pmid:12947796
    OpenUrlCrossRefPubMed
    1. Levey AS,
    2. Danovitch G,
    3. Hou S
    : Living donor kidney transplantation in the United States—Looking back, looking forward. Am J Kidney Dis 58: 343–348, 2011pmid:21783290
    OpenUrlCrossRefPubMed
    1. Davis CL,
    2. Delmonico FL
    : Living-donor kidney transplantation: A review of the current practices for the live donor. J Am Soc Nephrol 16: 2098–2110, 2005pmid:15930096
    OpenUrlAbstract/FREE Full Text
    1. Casagrande LH,
    2. Collins S,
    3. Warren AT,
    4. Ommen ES
    : Lack of health insurance in living kidney donors. Clin Transplant 26: E101–E104, 2012pmid:22050216
    OpenUrlCrossRefPubMed
  14. ↵
    1. Dew MA,
    2. Zuckoff A,
    3. DiMartini AF,
    4. DeVito Dabbs AJ,
    5. McNulty ML,
    6. Fox KR,
    7. Switzer GE,
    8. Humar A,
    9. Tan HP
    : Prevention of poor psychosocial outcomes in living organ donors: From description to theory-driven intervention development and initial feasibility testing. Prog Transplant 22: 280–292, quiz 293, 2012pmid:22951506
    OpenUrlCrossRefPubMed
  15. ↵
    1. Jacobs C,
    2. Johnson E,
    3. Anderson K,
    4. Gillingham K,
    5. Matas A
    : Kidney transplants from living donors: How donation affects family dynamics. Adv Ren Replace Ther 5: 89–97, 1998pmid:9554542
    OpenUrlPubMed
  16. ↵
    1. Gross CR,
    2. Messersmith EE,
    3. Hong BA,
    4. Jowsey SG,
    5. Jacobs C,
    6. Gillespie BW,
    7. Taler SJ,
    8. Matas AJ,
    9. Leichtman A,
    10. Merion RM,
    11. Ibrahim HN,
    12. RELIVE Study Group
    : Health-related quality of life in kidney donors from the last five decades: Results from the RELIVE study. Am J Transplant 13: 2924–2934, 2013pmid:24011252
    OpenUrlCrossRefPubMed
    1. Taler SJ,
    2. Messersmith EE,
    3. Leichtman AB,
    4. Gillespie BW,
    5. Kew CE,
    6. Stegall MD,
    7. Merion RM,
    8. Matas AJ,
    9. Ibrahim HN,
    10. RELIVE Study Group
    : Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades. Am J Transplant 13: 390–398, 2013pmid:23137211
    OpenUrlCrossRefPubMed
  17. ↵
    1. Jowsey SG,
    2. Jacobs C,
    3. Gross CR,
    4. Hong BA,
    5. Messersmith EE,
    6. Gillespie BW,
    7. Beebe TJ,
    8. Kew C,
    9. Matas A,
    10. Yusen RD,
    11. Hill-Callahan M,
    12. Odim J,
    13. Taler SJ,
    14. RELIVE Study Group
    : Emotional well-being of living kidney donors: Findings from the RELIVE Study. Am J Transplant 14: 2535–2544, 2014pmid:25293374
    OpenUrlCrossRefPubMed
  18. ↵
    1. Rubin DB
    : Multiple Imputation for Nonresponse in Surveys, Hoboken, NJ, John Wiley & Sons, 2004
  19. ↵
    SAS software user manual. SAS Institute, Cary, NC
  20. ↵
    1. Valapour M,
    2. Kahn JP,
    3. Bailey RF,
    4. Matas AJ
    : Assessing elements of informed consent among living donors. Clin Transplant 25: 185–190, 2011pmid:21158924
    OpenUrlCrossRefPubMed
  21. ↵
    1. DiMartini A,
    2. Cruz RJ Jr.,
    3. Dew MA,
    4. Fitzgerald MG,
    5. Chiappetta L,
    6. Myaskovsky L,
    7. DeVera ME
    : Motives and decision making of potential living liver donors: Comparisons between gender, relationships and ambivalence. Am J Transplant 12: 136–151, 2012pmid:22081865
    OpenUrlCrossRefPubMed
  22. ↵
    1. LaPointe Rudow D
    : Experiences of the live organ donor: Lessons learned pave the future. Narrat Inq Bioeth 2: 45–54, 2012pmid:24406767
    OpenUrlCrossRefPubMed
  23. ↵
    1. Dew MA,
    2. Jacobs CL,
    3. Jowsey SG,
    4. Hanto R,
    5. Miller C,
    6. Delmonico FL,
    7. United Network for Organ Sharing (UNOS),
    8. American Society of Transplant Surgeons,
    9. American Society of Transplantation
    : Guidelines for the psychosocial evaluation of living unrelated kidney donors in the United States. Am J Transplant 7: 1047–1054, 2007pmid:17359510
    OpenUrlCrossRefPubMed
  24. ↵
    United Network for Organ Sharing: Guidance for Developing and Implementing Procedures to Collect Post-Donation Follow-up Data from Living Donors. 2013. Available at: http://optn.transplant.hrsa.gov/ContentDocuments/Guidance_Post_Donation_Donor_Follow-Up.pdf. Accessed February 25, 2015
  25. ↵
    National Marrow Donor Program. Available at: https://bethematch.org/. Accessed February 24, 2015
  26. ↵
    1. Klarenbach S,
    2. Gill JS,
    3. Knoll G,
    4. Caulfield T,
    5. Boudville N,
    6. Prasad GVR,
    7. Karpinski M,
    8. Storsley L,
    9. Treleaven D,
    10. Arnold J,
    11. Cuerden M,
    12. Jacobs P,
    13. Garg AX,
    14. Donor Nephrectomy Outcomes Research (DONOR) Network
    : Economic consequences incurred by living kidney donors: A Canadian multi-center prospective study. Am J Transplant 14: 916–922, 2014pmid:24597854
    OpenUrlCrossRefPubMed
  27. ↵
    1. LaPointe RD,
    2. Hays R,
    3. Baliga P,
    4. Cohen DJ,
    5. Cooper M,
    6. Danovitch GM,
    7. Dew MA,
    8. Gordon EJ,
    9. Mandelbrot DA,
    10. McGuire S,
    11. Milton J,
    12. Moore DR,
    13. Morgievich M,
    14. Schold JD,
    15. Segev DL,
    16. Serur D,
    17. Steiner RW,
    18. Tan JC,
    19. Waterman AD,
    20. Zavala EY,
    21. Rodrigue JR
    : Consensus conference on best practices in live kidney donation: Recommendations to optimize education, access, and care. Am J Transplant 15: 914–292, 2015
    OpenUrlCrossRefPubMed
  28. ↵
    1. Woodle ES,
    2. Daller JA,
    3. Aeder M,
    4. Shapiro R,
    5. Sandholm T,
    6. Casingal V,
    7. Goldfarb D,
    8. Lewis RM,
    9. Goebel J,
    10. Siegler M,
    11. Paired Donation Network
    : Ethical considerations for participation of nondirected living donors in kidney exchange programs. Am J Transplant 10: 1460–1467, 2010pmid:20553449
    OpenUrlCrossRefPubMed
  29. ↵
    1. Andersen MH,
    2. Mathisen L,
    3. Øyen O,
    4. Wahl AK,
    5. Hanestad BR,
    6. Fosse E
    : Living donors’ experiences 1 wk after donating a kidney. Clin Transplant 19: 90–96, 2005pmid:15659140
    OpenUrlCrossRefPubMed
    1. Leichtman A,
    2. Abecassis M,
    3. Barr M,
    4. Charlton M,
    5. Cohen D,
    6. Confer D,
    7. Cooper M,
    8. Danovitch G,
    9. Davis C,
    10. Delmonico F,
    11. Dew MA,
    12. Garvey C,
    13. Gaston R,
    14. Gill J,
    15. Gillespie B,
    16. Ibrahim H,
    17. Jacobs C,
    18. Kahn J,
    19. Kasiske B,
    20. Kim J,
    21. Lentine K,
    22. Manyalich M,
    23. Medina-Pestana J,
    24. Merion R,
    25. Moxey-Mims M,
    26. Odim J,
    27. Opelz G,
    28. Orlowski J,
    29. Rizvi A,
    30. Roberts J,
    31. Segev D,
    32. Sledge T,
    33. Steiner R,
    34. Taler S,
    35. Textor S,
    36. Thiel G,
    37. Waterman A,
    38. Williams E,
    39. Wolfe R,
    40. Wynn J,
    41. Matas AJ,
    42. Living Kidney Donor Follow-Up Conference Writing Group
    : Living kidney donor follow-up: State-of-the-art and future directions, conference summary and recommendations. Am J Transplant 11: 2561–2568, 2011pmid:22054039
    OpenUrlCrossRefPubMed
  30. ↵
    1. de Graaf Olson W,
    2. Bogetti-Dumlao A
    : Living donors’ perception of their quality of health after donation. Prog Transplant 11: 108–115, 2001pmid:11871045
    OpenUrlCrossRefPubMed
  31. ↵
    1. Spital A,
    2. Jacobs C
    : Life insurance for kidney donors: Another update. Transplantation 74: 972–973, 2002pmid:12394839
    OpenUrlCrossRefPubMed
  32. ↵
    1. Clarke KS,
    2. Klarenbach S,
    3. Vlaicu S,
    4. Yang RC,
    5. Garg AX,
    6. Donor Nephrectomy Outcomes Research (DONOR) Network
    : The direct and indirect economic costs incurred by living kidney donors—A systematic review. Nephrol Dial Transplant 21: 1952–1960, 2006pmid:16554329
    OpenUrlCrossRefPubMed
  33. ↵
    1. Tong A,
    2. Chapman JR,
    3. Wong G,
    4. Kanellis J,
    5. McCarthy G,
    6. Craig JC
    : The motivations and experiences of living kidney donors: A thematic synthesis. Am J Kidney Dis 60: 15–26, 2012pmid:22305757
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Clinical Journal of the American Society of Nephrology: 10 (12)
Clinical Journal of the American Society of Nephrology
Vol. 10, Issue 12
December 07, 2015
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in CJASN.
Enter multiple addresses on separate lines or separate them with commas.
Emotional and Financial Experiences of Kidney Donors over the Past 50 Years: The RELIVE Study
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Emotional and Financial Experiences of Kidney Donors over the Past 50 Years: The RELIVE Study
Cheryl L. Jacobs, Cynthia R. Gross, Emily E. Messersmith, Barry A. Hong, Brenda W. Gillespie, Peg Hill-Callahan, Sandra J. Taler, Sheila G. Jowsey, Tim J. Beebe, Arthur J. Matas, Jonah Odim, Hassan N. Ibrahim
CJASN Dec 2015, 10 (12) 2221-2231; DOI: 10.2215/CJN.07120714

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Emotional and Financial Experiences of Kidney Donors over the Past 50 Years: The RELIVE Study
Cheryl L. Jacobs, Cynthia R. Gross, Emily E. Messersmith, Barry A. Hong, Brenda W. Gillespie, Peg Hill-Callahan, Sandra J. Taler, Sheila G. Jowsey, Tim J. Beebe, Arthur J. Matas, Jonah Odim, Hassan N. Ibrahim
CJASN Dec 2015, 10 (12) 2221-2231; DOI: 10.2215/CJN.07120714
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosures
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

Original Articles

  • Association of Polypharmacy with Kidney Disease Progression in Adults with CKD
  • The Effect of Atrasentan on Kidney and Heart Failure Outcomes by Baseline Albuminuria and Kidney Function
  • Collectin11 and Complement Activation in IgA Nephropathy
Show more Original Articles

Renal Transplantation

  • Proteins in Preservation Fluid as Predictors of Delayed Graft Function in Kidneys from Donors after Circulatory Death
  • Donor-Recipient Weight and Sex Mismatch and the Risk of Graft Loss in Renal Transplantation
  • A Case-Based Analysis of Whether Living Related Donors Listed for Transplant Share ESRD Causes with Their Recipients
Show more Renal Transplantation

Cited By...

  • Helping More Patients Receive a Living Donor Kidney Transplant
  • Development and feasibility of a guided and tailored internet-based cognitive-behavioural intervention for kidney donors and kidney donor candidates
  • Google Scholar

Similar Articles

Related Articles

  • PubMed
  • Google Scholar

Keywords

  • kidney donation
  • quality of life
  • renal transplantation
  • Cost of Illness
  • Emotions
  • Living Donors
  • motivation
  • Social Support
  • tissue donors
  • Vulnerable Populations

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe to ASN Journals

© 2022 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire